Bridge Oncology, a premier partner for comprehensive oncology service line transformation, today announced the addition of Lynn Whitehair, MBA, ACHE, as Director of Oncology Services, as the firm continues to expand its capabilities. Whitehair adds operational leadership as Bridge Oncology builds upon radiation oncology expertise to partner with health systems, hospitals and oncology practices across medical oncology, infusion services, pharmacy, theranostics and enterprise oncology strategy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260721994829/en/
Lynn Whitehair, Director of Oncology Services at Bridge Oncology
How can a health system build a high-performing oncology service line?
Whitehair brings more than 25 years of experience, concentrated in running high-performing oncology service lines that require simultaneous coordination of clinical operations, financial performance and patient access. Bridge Oncology offers a unique model of pairing active clinical leadership with seasoned healthcare operations expertise, enabling clients to make decisions that improve both patient care and long-term financial sustainability.
In her new role, she will lead the service line strategy and operational excellence initiatives, including operational assessments, infusion and medical oncology workflow optimization, program development, accreditation readiness, workforce planning, patient access improvement, facility program expansion planning and implementation support to help cancer programs achieve measurable operational, financial, and clinical outcomes.
“Cancer care is becoming increasingly interconnected, more complex and more specialized than ever before,” said Arpit Chhabra, M.D., Co-founder of Bridge Oncology and Radiation Oncologist, Director of Theranostics and Director of Education at New York Proton Center. “Lynn has spent her career building high-performing oncology programs, and her experience further strengthens our ability to help clients improve access, streamline operations and build comprehensive service lines across the oncology enterprise.”
How are oncology programs managing rising reimbursement pressure and margin compression?
Oncology programs across the country are facing mounting reimbursement and regulatory pressure, including the anticipated 2027 Medicare Proposed Rule, that are reshaping how service lines operate. Whitehair’s expertise will help clients defend clinical margins, improve efficiency, enhance patient access and integrate care across the oncology continuum. As healthcare organizations seek experienced partners who can implement meaningful operational improvements, Bridge Oncology is evolving to provide execution-focused support across the broader oncology enterprise.
“Oncology programs are facing unprecedented financial and operational pressures, and they need practical solutions, not just advice,” said Jordan Johnson, Co-founder and CEO of Bridge Oncology. “Lynn brings a proven track record of helping health systems navigate complexity, improve performance and deliver better patient care. Her addition complements our multidisciplinary team to support organizations across the oncology continuum and turn strategy into measurable results for long-term success.”
Whitehair has provided operational leadership at some of the nation’s premier cancer programs across both academic and community settings. Most recently, she served as Senior Director of Operations at Emory Healthcare Winship Cancer Institute, where she helped lead the large-scale expansion of oncology services, workflow redesign, workforce planning, and financial management. She also previously served in cancer service line leadership roles at Baylor Scott & White and Memorial Hermann Healthcare Systems.
Bridge Oncology continues to invest in helping health systems bridge the gap to the future of oncology through integrated expertise, hands-on execution, and comprehensive service line transformation. For more information on how Bridge Oncology helps organizations build, optimize and grow comprehensive oncology programs, visit www.bridgeoncology.com.
About Bridge Oncology
Bridge Oncology is the premier partner for comprehensive oncology service line transformation, bridging the gap to the future of oncology programs. With more than two decades of combined experience across radiation oncology, medical oncology, and the broader cancer care continuum, Bridge Oncology serves as a fiercely independent advocate for health systems, hospitals, and physician groups navigating reimbursement dislocation, margin compression, and operational complexity. Bridge embeds directly within client organizations, aligning clinical, operational, and financial performance to build oncology programs that are sustainable, defensible, and built for what comes next. Learn more at www.bridgeoncology.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260721994829/en/
Media gallery
